Mutant KRAS–SOS1–WT RAS allosteric signaling promotes growth of KRAS-mutated pancreatic cancer cell xenografts [77], but has not been assessed for mutant HRAS- or NRAS-dependent transformation. The gene discussed is NRAS; the disease is familial pancreatic carcinoma.